CN Stock MarketDetailed Quotes

600422 KPC Pharmaceuticals, Inc.

  • 19.83
  • -0.27-1.34%
Not Open 02/21 15:00 CST
15.03BMarket Cap37.92P/E (TTM)

About KPC Pharmaceuticals, Inc. Company

The company was founded in March 1951 and listed on the Shanghai Stock Exchange in December 2000. The company has deep professional pharmaceutical experience, and is a national key high-tech enterprise and one of the top 100 enterprises in China's pharmaceutical industry. Relying on Yunnan's rich plant resources, Kunyao Group has successively developed more than 40 new natural medicine products with advanced standards at home and abroad, including three series of artemisia, 37, and Tianma, specialty traditional Chinese medicine, and ethnic medicine. At the same time, inheriting the essence of Chinese medicine, it has created a number of fine Chinese medicines represented by Shenling, Spleen, Stomach, and Liver Relief Granules, etc., gradually forming the four core business patterns of chronic disease management, health consumption, overseas international, and beautiful health. The industry in which the company is located is pharmaceutical manufacturing. The business area covers the entire pharmaceutical industry chain. The core business covers pharmaceutical R&D, production and sales, pharmaceutical distribution, and the health industry. The business development is based on mainland China and is actively deployed globally. The company's core products include Kunyao Xuesetong series, Tianmarin series, artemether series, Shenling, Spleen and Stomach Granules, Shu Lian Granules, Fragrant Sand Calming Granules, Sodium Hyaluronate Injection, Alfacalcidol Softgels, and Caoxalcin Softgels. The company was selected as a “National Technological Innovation Demonstration Enterprise” by the Ministry of Industry and Information Technology, the “2019 Top 100 Chinese Pharmaceutical Innovative Enterprises”, “Top 500 Chinese Enterprise Patents”, and “2022 Brand with the Highest Recommendation Rate for Chinese Pharmacy Clerk” by the China Pharmaceutical Enterprise Management Association.

Company Profile

Short Name-A昆药集团
Company NameKPC Pharmaceuticals, Inc.
Listing Date12/06/2000
Issue Price10.22
Shares Offered40.00M share
Listed ExchangeSH Stock Exchange
Legal RepresentativeWei Yan
General ManagerWei Yan
SecretaryMengxun Zhang
Accounting FirmKPMG Huazhen Certified Public Accountants (Special General Partnership)
Securities RepresentativeYu Dong
Legal CounselYunnan Haihe Law Firm
Office AddressNo. 166, Medical Road, National High-tech Development Zone, Kunming, Yunnan
Zip Code650106
Registered AddressNo. 166, Medical Road, National High-tech Development Zone, Kunming, Yunnan
Business License530000000014415
BusinessProcurement, production and sale of raw materials and preparations of Chinese and Western medicine, chemical raw materials, intermediates, reagents, packaging materials, extracts, Chinese medicine tablets, agricultural by-products and Chinese herbal medicines (cultivation, acquisition and sale), industrial hemp cultivation, R&D, flower and leaf processing, domestic trade, material supply and marketing, goods and technology import and export business, technology development, consulting services, mechanical processing, pharmaceutical equipment manufacturing, installation and maintenance business, pharmaceutical engineering design, medical device management, foreign aid projects.

Company Executives

  • Name
  • Position
  • Salary
  • Huawei Qiu
  • Chairman,Director
  • --
  • Wei Yan
  • Vice Chairman,Director,President
  • --
  • Zheng Liang
  • Director
  • --
  • Ting Guo
  • Director
  • --
  • Hui Zhou
  • Director
  • --
  • Hongshen Li
  • Director
  • --
  • Ke Liu
  • Independent Director
  • 100.00K
  • Jinguo Xin
  • Independent Director
  • 100.00K
  • Mengxun Zhang
  • Company Secretary
  • 425.40K
  • Yu Dong
  • Securities Affairs Representative
  • --
  • Jiang Zhong
  • Chairman of the Supervisory Board,Supervisor
  • --
  • Jinfeng Shao
  • Supervisor
  • --
  • Kang Deng
  • Supervisor
  • --
  • Junfeng Liu
  • VP
  • 427.70K
  • Li Meng
  • VP
  • 405.40K
  • Kai Xi
  • VP
  • --
  • Zhiqiang Sun
  • Finance Director
  • --
  • Linxi Li
  • Employee Representative Supervisor
  • 477.70K
  • Wensen Zhang
  • Employee Representative Supervisor
  • 316.00K


Analyst Rating

No Data

Price Target

No Data

Heat List
Latest Price